MD, Marmara Universitesi
Yale-New Haven Hospital
Psychiatry, American Board of Psychiatry and Neurology
Ozbay F, Sharma V, Kaufman J, McEwen B, Charney D, Southwick S. Neurobiological factors underlying psychosocial moderators of childhood stress and trauma. Cambridge University Press, Cambridge, UK 2010;: 189-198.
Zdanys KF, Kleiman TG, Zhang H, Ozbay F, MacAvoy MG, Gelernter J, van Dynck CH. BDNF variants, premorbid educational attainment, and disease characteristics in Alzheimer's disease: an exploratory study. J Alzheimers Dis. 2009; 17(4): 887-898.
Southwick S, Ozbay F, Charney D, McEwen B. Adaptation to Stress and Psychobiological Mechanisms of Resilience, Biobehavioral Resilience to Stress. CRC Press Taylor & Francis Group, Boca Raton, FL 2008;: 91-115.
Ozbay F, Fitterling H, Charney D, Southwick S. Social support and resilience to stress across the life span: a neurobiologic framework. Curr Psychiatry Rep 2008; 10(4): 304-310.
Cokol M, Ozbay F, Rodriguez-Esteban R. Retraction rates are on the rise. EMBO Rep 2008 Jan; 9(1): 2.
Ozbay F, Johnson C, Dimoulas E, Morgan C, Southwick S. Social Support and Resilience to Stress: From Neurobiology to Clinical Practice. Psychiatry 2007; 4(5): 35-40.
Ozbay F, Wigg KG, Tahir E, Asherson P, Yazgan Y, Sandor P, Barr CL. Analysis of the Dopamine Beta Hydroxylase Gene in Gilles de la Tourette Syndrome. American Journal of Medical Genetics 2006 Sep; 141(6): 673-677.
Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS, Rosenheck R, Price LH, Southwick S, Yang B, Gelernter J. Brain Derived Neurotrophic Factor (BDNF) Genetic Variants and Alzheimer’s Disease, Affective Disorders, Posttraumatic Stress Disorder, Schizophrenia and Substance Dependence. American Journal of Medical Genetics 2006 Jun; 141(4): 387-393.
Bereket A, Turan S, Karaman MG, Haklar G, Ozbay F, Yazgan MY. Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: Effect of methylphenidate treatment. Hormone Research 2005 Mar; 63(4): 159-164.
Xu C, Ozbay F, Wigg K, Shulman R, Tahir E, Yazgan Y. Evaluation of the genes for the adrenergic receptors alpha 2A and alpha 1C and gilles de la tourette syndrome. American Journal of Medical Genetics 2003 May; 119(1): 54-59.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Ozbay during 2015 and/or 2016. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.